Synthesis, Structural Characterization, Solution Chemistry, and Preliminary Biological Studies of the Ruthenium(III) Complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)]·(DMSO), the Thiazole Analogues of Antitumor ICR and NAMI-A
- 29 May 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 43 (13) , 3863-3870
Abstract
Two ruthenium(III) complexes bearing the thiazole ligand, namely, thiazolium (bisthiazole) tetrachlororuthenate (I, TzICR) and thiazolium (thiazole, DMSO) tetrachlororuthenate (II, TzNAMI) were prepared and characterized. The crystal structures of both complexes were solved by X-ray diffraction methods and found to match closely those of the corresponding imidazole complexes. The behavior in aqueous solution of bothTzICR and TzNAMI was analyzed spectroscopically. The time-dependent spectrophotometric profiles resemble closely those of the related ICR and NAMI-A anticancer compounds, respectively. It is observed that replacement of imidazole with thiazole, a less basic ligand, produces a significant decrease of the ligand exchange rates in the case of the NAMI-like compound. The main electrochemical features of these ruthenium(III) thiazole complexes were determined and compared to those of ICR and NAMI-A. Moreover, some preliminary data were obtained on their biological properties. Notably, both complexes exhibit higher reactivity toward serum albumin than toward calf thymus DNA; cytotoxicity is negligible in line with expectations. A more extensive characterization of the pharmacological properties in vivo is presently in progress.Keywords
This publication has 23 references indexed in Scilit:
- Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR)Metal-Based Drugs, 2000
- Studies on the interactions between human serum albumin and imidazolium [trans-tetrachlorobis(imidazol)ruthenate(III)]Journal of Inorganic Biochemistry, 1999
- SIR97: a new tool for crystal structure determination and refinementJournal of Applied Crystallography, 1999
- Comparison of the Antiproliferative Activity of Two AntitumourRuthenium(III) Complexes With Their Apotransferrin andTransferrin‐Bound Forms in a Human Colon Cancer Cell LineMetal-Based Drugs, 1995
- PAUTO – an automatic procedure for crystal structure solution by the Patterson method in the CAOS packageJournal of Applied Crystallography, 1994
- Aquation of the anticancer complex trans-[RuCl4(Him)2]–(Him = imidazole)J. Chem. Soc., Dalton Trans., 1994
- Protein‐binding Properties of two Antitumour Ru(III) Complexes toHuman Apotransferrin and ApolactoferrinMetal-Based Drugs, 1994
- Synthesis, molecular structure, and chemical behavior of hydrogen trans-bis(dimethyl sulfoxide)tetrachlororuthenate(III) and mer-trichlorotris(dimethyl sulfoxide)ruthenium(III): the first fully characterized chloride-dimethyl sulfoxide-ruthenium(III) complexesInorganic Chemistry, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Synthesis, molecular structure, and tumor-inhibiting properties of imidazolium trans-bis(imidazole)tetrachlororuthenate(III) and its methyl-substituted derivativesInorganic Chemistry, 1987